scholarly article | Q13442814 |
P50 | author | Waleria Hryniewicz | Q20029115 |
Marek Gniadkowski | Q112336229 | ||
Maja Abram | Q59122689 | ||
Anna Baraniak | Q59144534 | ||
Marija Guzvinec | Q87458333 | ||
P2093 | author name string | Arjana Tambic Andrasevic | |
Marko Jelic | |||
Radosław Izdebski | |||
Iva Butic | |||
Iva Koscak | |||
P2860 | cites work | Surveillance for antimicrobial resistance in Croatia | Q28366739 |
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 | ||
Metallo-beta-lactamases: the quiet before the storm? | Q33755227 | ||
Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria | Q33770194 | ||
Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance | Q33982709 | ||
Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii | Q34042171 | ||
Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235. | Q34044909 | ||
Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland | Q34509756 | ||
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study | Q34932869 | ||
Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms | Q35007624 | ||
Pseudomonas aeruginosa: resistance to the max | Q35084559 | ||
Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact | Q35183983 | ||
Establishing clonal relationships between VIM-1-like metallo-beta-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. | Q35221062 | ||
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections | Q36095065 | ||
Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex | Q36098603 | ||
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals | Q36313186 | ||
FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy | Q36505578 | ||
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy. | Q36949459 | ||
Molecular characterization of blaNDM-1 in a sequence type 235 Pseudomonas aeruginosa isolate from France | Q36969995 | ||
Diversity, epidemiology, and genetics of class D beta-lactamases | Q37590023 | ||
Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. | Q40133112 | ||
Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. | Q40625683 | ||
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. | Q41183478 | ||
Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals | Q41886730 | ||
Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from Croatia | Q42110677 | ||
Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa | Q42111460 | ||
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain | Q42111506 | ||
Characterization of In111, a class 1 integron that carries the extended-spectrum beta-lactamase gene blaIBC-1. | Q42605128 | ||
Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic | Q42649144 | ||
Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types | Q42850221 | ||
Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons. | Q43168020 | ||
Dissemination of metallo-β-lactamase-producing Pseudomonas aeruginosa of sequence type 235 in Asian countries. | Q43168111 | ||
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain | Q43189772 | ||
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? | Q43874264 | ||
Morpho-structural variations of bacterial spores after treatment in steam vacuum assisted autoclave | Q44006534 | ||
Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa | Q44616565 | ||
Identification of PER-1 extended-spectrum beta-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia | Q46218982 | ||
Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study | Q47844514 | ||
Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary. | Q54546192 | ||
Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type | Q84581561 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Croatia | Q224 |
Pseudomonas aeruginosa | Q31856 | ||
multiple drug resistance | Q643839 | ||
P304 | page(s) | 6277-6283 | |
P577 | publication date | 2014-07-28 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia | |
P478 | volume | 58 |
Q99555879 | Antibiotic Resistance Characteristics of Pseudomonas aeruginosa Isolated from Keratitis in Australia and India |
Q40237644 | Applying a PCR-based open-reading frame typing method for easy genotyping and molecular epidemiological analysis of Pseudomonas aeruginosa |
Q37202044 | Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia. |
Q92935128 | Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria |
Q40056971 | Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain. |
Q52592585 | Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data. |
Q35385287 | Persistence and epidemic propagation of a Pseudomonas aeruginosa sequence type 235 clone harboring an IS26 composite transposon carrying the blaIMP-1 integron in Hiroshima, Japan, 2005 to 2012 |
Q42334062 | VIM-2-Producing Pseudomonas spp. in Uruguay: Sequence Types, Pulsotypes, and Class 1 Integrons Including New Variable Regions Featuring blaVIM-2 and blaGES-7. |
Search more.